Melville, NY Kedrion Biopharma, specialists in collecting and fractionating blood plasma, is in the final stages of a $120 million upgrade to its only U.S. production facility, which spans 11 acres on Duryea Rd. along the Rte. 110 corridor. The expansion will add 80 full-time, permanent jobs to the Long Island region.